Kotak noted that Cognizant’s deal mix has become more balanced between cost optimisation and innovation-led engagements, a ...

The month has set a new record for monthly fundraising in the domestic capital markets, driven by two heavyweight listings — ...

Evommune is set to make its stock market debut next week, but the biotech company is keeping investors guessing about its final share price.

For now, only Bengaluru-based IT titans Infosys Ltd and Wipro Ltd have their shares listed in both the US and India, and an ...